Skip Nav Destination
Issues
1 October 2017
-
Cover Image
Cover Image
The five-year survival rate for patients with oral cancer remains low, in part because diagnosis often occurs at a late stage. The standard of care for evaluation of oral lesions—visual examination under white light illumination—is strongly dependent on the expertise and experience of the clinician. There is a need for tools that can aid clinicians by facilitating early, objective identification of oral neoplasia. Multi-modal optical imaging has the potential to help identify oral neoplasia in real time. Implementation of automated image analysis can improve the accessibility and utility of adjunctive optical imaging technologies. The cover shows a micrograph of an image (circle at left) acquired in vivo from an oral lesion site using a fiberoptic fluorescence microscope; it also shows the corresponding processed image (circle at right) that was automatically generated in real time at the point-of-care. The field of view is 720 microns in diameter and the bright dots are cell nuclei. Nuclei classified as abnormal by the processing algorithm are outlined in red, while nuclei classified as normal are outlined in yellow. The automated algorithm gave an overall prediction of "neoplastic" for this oral site; subsequent pathology results indicated severe dysplasia. See the article by Quang et al. (beginning on page 563) for more information. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Editorial
Research Articles
Effect of Green Tea Supplements on Liver Enzyme Elevation: Results from a Randomized Intervention Study in the United States
Zheming Yu; Hamed Samavat; Allison M. Dostal; Renwei Wang; Carolyn J. Torkelson; Chung S. Yang; Lesley M. Butler; Thomas W. Kensler; Anna H. Wu; Mindy S. Kurzer; Jian-Min Yuan
In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation
Ester Borras; Kyle Chang; Mala Pande; Amanda Cuddy; Jennifer L. Bosch; Sarah A. Bannon; Maureen E. Mork; Miguel A. Rodriguez-Bigas; Melissa W. Taggart; Patrick M. Lynch; Y. Nancy You; Eduardo Vilar
Author Choice
RETRACTED: Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer
Feng Jin; Jose Thaiparambil; Sri Ramya Donepudi; Venkatrao Vantaku; Danthasinghe Waduge Badrajee Piyarathna; Suman Maity; Rashmi Krishnapuram; Vasanta Putluri; Franklin Gu; Preeti Purwaha; Salil Kumar Bhowmik; Chandrashekar R. Ambati; Friedrich-Carl von Rundstedt; Florian Roghmann; Sebastian Berg; Joachim Noldus; Kimal Rajapakshe; Daniel Gödde; Stephan Roth; Stephan Störkel; Stephan Degener; George Michailidis; Benny Abraham Kaipparettu; Balasubramanyam Karanam; Martha K. Terris; Shyam M. Kavuri; Seth P. Lerner; Farrah Kheradmand; Cristian Coarfa; Arun Sreekumar; Yair Lotan; Randa El-Zein; Nagireddy Putluri
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.